These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 21398104

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination.
    LaForce C, Weinstein C, Nathan RA, Weinstein SF, Staudinger H, Meltzer EO.
    J Asthma; 2011 Aug; 48(6):625-31. PubMed ID: 21726121
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial.
    Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, Banerjee S, Staudinger H.
    Int J Chron Obstruct Pulmon Dis; 2012 Aug; 7():43-55. PubMed ID: 22334768
    [Abstract] [Full Text] [Related]

  • 8. Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.
    Berger WE, Bensch GW, Weinstein SF, Skoner DP, Prenner BM, Shekar T, Nolte H, Teper AA.
    Pediatr Pulmonol; 2014 May; 49(5):441-50. PubMed ID: 24019197
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials.
    Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, Gates D, Staudinger H.
    Int J Chron Obstruct Pulmon Dis; 2012 May; 7():73-86. PubMed ID: 22334770
    [Abstract] [Full Text] [Related]

  • 10. Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma.
    Maspero JF, Nolte H, Chérrez-Ojeda I, P04139 Study Group.
    J Asthma; 2010 Dec; 47(10):1106-15. PubMed ID: 20874458
    [Abstract] [Full Text] [Related]

  • 11. Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction.
    Sheth K, Wasserman RL, Lincourt WR, Locantore NW, Carranza-Rosenzweig J, Crim C.
    Int J Clin Pract; 2006 Oct; 60(10):1218-24. PubMed ID: 16981966
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mometasone furoate/formoterol in the treatment of persistent asthma.
    Berger WE.
    Expert Rev Respir Med; 2011 Dec; 5(6):739-46. PubMed ID: 22082160
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
    Sharafkhaneh A, Southard JG, Goldman M, Uryniak T, Martin UJ.
    Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
    [Abstract] [Full Text] [Related]

  • 17. Real-world assessment of a metered-dose inhaler with integrated dose counter.
    Wasserman RL, Sheth K, Lincourt WR, Locantore NW, Rosenzweig JC, Crim C.
    Allergy Asthma Proc; 2006 Feb; 27(6):486-92. PubMed ID: 17176783
    [Abstract] [Full Text] [Related]

  • 18. A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD.
    Quinn D, Seale JP, Reisner C, Fischer T, Golden M, Fernandez C, Darken P, St Rose E, Thomas M, Tardie G, Orevillo C.
    Respir Med; 2014 Sep; 108(9):1327-35. PubMed ID: 25060541
    [Abstract] [Full Text] [Related]

  • 19. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
    Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, Lutsky B.
    Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG.
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.